Systemic therapy and prognosis of older patients with stage II/III breast cancer: A large-scale analysis of the Japanese Breast Cancer Registry - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34293663/
Chemotherapy use was lower among older patients with stage II/III breast cancer. Those with TN and HER2-positive BC had a lower BCSS than their younger counterparts. Chemotherapy may be beneficial...
Use of aromatase inhibitors in patients with breast cancer is associated with deterioration of bone microarchitecture and density - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34283901/
doi: 10.20945/2359-3997000000385. Online ahead of print. 1 Divisão de Endocrinologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brasil. 2 Departamento de Oncologia, Hospital Federal Cardoso Fontes, Rio...
Health-Related Quality of Life Among Patients With HR+/HER2- Early Breast Cancer - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34256965/
Patient-reported HRQOL among patients with HR+/HER2- early breast cancer who were disease-free was high, with reported scores comparable to normative scores. These results improve our understanding of HRQOL among patients...
-
Naveed Saleh, MD, MS – Skipta Team5yrKey Points • Implications: “Patient-reported HRQOL among patients with HR+/HER2– early breast cancer who were disease-free was high, with reported scores comparable to normative scores. These results improve our understanding of Show More
Institutions Treating Breast Cancer Patients of a Low Socioeconomic Status Achieve Multidisciplinary Quality Standards at Lower Rates - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34269942/
doi: 10.1245/s10434-021-10451-x. Online ahead of print. 1 Department of Surgery, Lankenau Medical Center, Wynnewood, PA, USA. [email protected]. 2 Department of Surgery, Lankenau Medical Center, Wynnewood, PA, USA. Background: The National...
Molecular Imaging, How Close to Clinical Precision Medicine in Lung, Brain, Prostate and Breast Cancers - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34269972/
doi: 10.1007/s11307-021-01631-y. Online ahead of print. 1 NHC and CAMS Key Laboratory of Molecular Probe and Targeted Theranostics, Molecular Imaging Research Center (MIRC), Harbin Medical University, 766 Xiangan N street,...